Deutsche Bank Reiterates Hold Rating on AstraZeneca plc Shares

Strategic Insights -

AstraZeneca plc, a global biopharmaceutical company, has been the subject of several analyst ratings in recent days. Deutsche Bank reaffirmed its hold rating on the company's shares, maintaining a target price of GBX 4,800 ($72.40). This move is part of a broader trend of analyst reassessments, with several other firms also weighing in on the company's stock.

The stock has experienced significant fluctuations, with a 1-year low of GBX 3718.5002 and a 1-year high of GBX 5750.00. The company's market capitalization stands at Au56.646 billion. Analysts at multiple firms, including Berenberg Bank, Baader Helvea, Jefferies Group, and Liberum Capital, have also issued hold or buy ratings on the stock, with target prices ranging from GBX 4,800 to GBX 5,800 ($72.40 to $87.48).

Despite the mixed analyst views, AstraZeneca plc remains a significant player in the global biopharmaceutical industry. The company focuses on developing and commercializing prescription medicines for six key areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. With a diverse portfolio and a strong market presence, AstraZeneca plc continues to be an important stock for investors to watch.

Key Takeaways:

  • Deutsche Bank reiterated its hold rating on shares of AstraZeneca plc with a GBX 4,800 ($72.40) target price.
  • Analysts at Berenberg Bank, Baader Helvea, Jefferies Group, and Liberum Capital have also issued hold or buy ratings on the stock.
  • The company has a 1-year low of GBX 3718.5002 and a 1-year high of GBX 5750.00.
  • The stock has a 50-day moving average of GBX 4631.10 and a 200-day moving average of GBX 4502.
  • A number of analysts have provided target prices for the stock, including GBX 4,800, GBX 4,950, GBX 5,600, and GBX 5,800 ($72.40, $74.66, $84.46, and $87.48).
  • Eight analysts have rated the stock with a sell rating, twelve have given a hold rating, and nine have assigned a buy rating to the company.
  • The company has a market capitalization of Au56.646 billion.

Statistics:

  • GBX 4,800: Deutsche Bank's target price for AstraZeneca plc shares.
  • GBX 4,626.69: The company's consensus price target.
  • GBX 3718.5002: The company's 1-year low.
  • GBX 5750.00: The company's 1-year high.
  • GBX 4631.10: The company's 50-day moving average.
  • GBX 4502: The company's 200-day moving average.
  • Au56.646 billion: The company's market capitalization.

Sources:

  • Deutsche Bank research note, Friday morning.
  • Berenberg Bank research note, Thursday.
  • Baader Helvea research note, Thursday.
  • Jefferies Group research note, Thursday.
  • Liberum Capital research note, Thursday.
  • AstraZeneca PLC official website.
  • 2015 Global Data Point.